Blaber, Michael http://orcid.org/0000-0002-6856-1643
Funding for this research was provided by:
Trefoil Therapeutics (RF02551)
Article History
Received: 20 July 2022
Revised: 29 September 2022
Accepted: 2 October 2022
First Online: 12 October 2022
Declarations
:
: MB is a cofounder and has equity ownership in Trefoil Therapeutics Inc.